Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Sanofi-aventis Welcomes The European Medicines Agency's Statement On Lantus® Safety
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced that following the review of the available evidence on Lantus® (insulin glargine [rDNA] injection), the European Medicines Agency"s Committee for Medicinal Products for Human Use (CHMP) confirmed the product"s safety and concluded that changes to the prescribing advice are not necessary. The EMEA issued a press-release stating that they have re-confirmed their initial assessment, based on an
generic viagra online
Scientists Follow Live Infection By Food-poisoning Bacteria Listeria
Scientists in Portugal and France managed to follow the patterns of gene expression in food-poisoning bacteria Listeria monocytogenes (L. monocytogenes) live during infection for the first time. The work about to be published in PLoS Pathogens shows how the bacterial genome shifts to better adapt to infection by activating genes involved in virulence and subversion of the host defences, as well as adaptation to the host conditions. This is the first time that the molecular interactions between L. monocytogenes and its host, as they occur during the different steps of infection, are followed in real time paving the way, not only to the development of new therapies against this potentially lethal bacterium, but also for the study of other pathogen/host interactions.
News of the day
AccuVein Launches First Portable, Non-Contact Vein Illumination Device
AccuVein LLC announced the launch of AccuVein AV300, the world"s first hand-held, non-contact vein illumination device that helps healthcare professionals locate hard-to-find veins. IV starts and blood draws (venipuncture) can be a of patient anxiety and discomfort, and accessing veins in difficult patients can take up to 10 minutes and require multiple needle sticks. Venipuncture is the most common invasive medical procedure with an estimated 2.7 million procedures conducted every day in the United States alone. The AV300 can help reduce the need for multiple needle sticks, with the goal of improving patient care and the time to access veins.
Cardiovascular

Dr. David B. Samadi Introduces New Prostate Cancer Care Center For Robotic Surgery Patients At Mount Sinai Medical Center

The Mount Sinai Medical Center has a new re center for prostate cancer treatment. Led by David B. Samadi, M.D., Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology, the new state-of-the-art facility at 625 Madison Avenue in New York City specializes in pre- and post-surgery care for patients who undergo a robotic prostatectomy at Mount Sinai"s main campus. It also provides expertise in the treatment of other urologic cancers, including bladder and kidney. A multilingual staff offers assistance with patient travel arrangements, accommodations, and translation services when required. "The care that patients receive before and after undergoing robotic surgery is as crucial to their recovery as the procedure itself," said Dr. Samadi. "At our new facility, patients are welcomed by a caring and compassionate staff that is ready to answer their questions on a variety of issues, including concerns about their continence, kegel exercises and sexual health. There"s an ample array of learning materials and brochures, and high-definition TV screens play educational tapes, presentations and DVDs. By the time I see my patients, they are at ease, well-informed and ready to take the next steps in their prostate care. Once they undergo robotic surgery at Mount Sinai"s main campus, our new facility offers them the additional care that they need on their road to recovery." Also known as Robotic Assisted Laparoscopic Prostatectomy, robotic prostatectomy is a minimally invasive type of prostate cancer surgery that utilizes a robotic surgical unit called the da Vinci system, manufactured by Intuitive Surgical. This prostate surgery is a revolutionary and advanced procedure that profoundly reduces blood loss, pain, recovery time, hospital stays, trauma to surrounding tissue and the drastically reduced side effects of other treatments such as incontinence and sexual dysfunction. "Our goal," Dr. Samadi says, "is not just survival, but to improve the patients" quality of life." One of the nation"s leading urologic oncologists, specializing in robotics and minimally invasive surgery for prostate cancer, Dr. Samadi has achieved great success treating more than 1,800 prostate cancer patients from around the world. He is one of very few urologic oncologic surgeons in the United States trained in all three primary areas of surgery -- open, laparoscopic, and robotic. Patients interested in obtaining more information about Mount Sinai"s new prostate cancer care facility and Robotic Assisted Laparoscopic Prostatectomy may call 212-241-8779 or visit, http://www.roboticoncology.com. The Mount Sinai Medical Center


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009